Suppr超能文献

探索差异:印度2型糖尿病门诊患者中初治患者、常规使用者和惰性患者的比较分析

Exploring disparities: A comparative analysis of insulin-naïve, regular users, and inertia patients among type 2 diabetes mellitus outpatients in India.

作者信息

Atal Shubham, Bohra Arwa, Kalra Shamsher S, Balakrishnan S, Joshi Rajnish

机构信息

Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, India.

Department of General Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, India.

出版信息

J Family Med Prim Care. 2024 Oct;13(10):4244-4251. doi: 10.4103/jfmpc.jfmpc_87_24. Epub 2024 Oct 18.

Abstract

INTRODUCTION

Insulin utilization pattern varies greatly in type 2 diabetes mellitus (T2DM) patients. Clinical inertia in treatment intensification hinders glycemic control in T2DM management. This study investigated insulin prescription trends and various predictors among insulin naive, user, and insulin inertia (II) patients in T2DM.

METHODOLOGY

A retrospective analysis of T2DM patient records from the diabetes clinic at a tertiary care center was conducted. Data on socio-demographics, anthropometry, disease characteristics, comorbidities, adherence, and medication prescribing patterns were collected. Analysis was done using tests of significance, odds ratio (OR), and multivariate logistic regression.

RESULTS

A total of 950 records were analyzed, with 17.3% of patients identified as insulin users (IU), 70.9% being insulin-naïve (IN), and 11.8% having II. IUs had significantly higher glycemic levels including HbA1c, fasting, postprandial, and random blood sugars compared to the other groups. Higher HbA1c levels were associated with significantly increased odds of insulin usage (OR: 3.46, confidence interval (CI): 1.94-6.16), while individuals taking sulfonylureas had lower odds of insulin usage (OR: 0.27, CI: 0.08-0.91). A significant association was also seen with the total number of oral antidiabetic drugs prescribed (four drugs; OR: 15.6, and five drugs; OR: 9.1). Other factors did not show a significant association. The regression model showed HbA1c level as low as 7.9% could indicate a future insulin requirement in 22% of patients.

CONCLUSION

The study outlines differences in characteristics and parameters among T2DM patients who require or do not require insulin and highlights the challenges in insulin initiation in Indian T2DM patients. Findings on II underscore the need for timely treatment intensification.

摘要

引言

2型糖尿病(T2DM)患者的胰岛素使用模式差异很大。治疗强化方面的临床惰性阻碍了T2DM管理中的血糖控制。本研究调查了T2DM中初治胰岛素患者、胰岛素使用者和胰岛素惰性(II)患者的胰岛素处方趋势及各种预测因素。

方法

对一家三级护理中心糖尿病门诊的T2DM患者记录进行回顾性分析。收集了社会人口统计学、人体测量学、疾病特征、合并症、依从性和药物处方模式等数据。使用显著性检验、比值比(OR)和多变量逻辑回归进行分析。

结果

共分析了950份记录,其中17.3%的患者被确定为胰岛素使用者(IU),70.9%为初治胰岛素患者(IN),11.8%有II。与其他组相比,IU的血糖水平显著更高,包括糖化血红蛋白(HbA1c)、空腹血糖、餐后血糖和随机血糖。较高的HbA1c水平与胰岛素使用几率显著增加相关(OR:3.46,置信区间(CI):1.94 - 6.16),而服用磺脲类药物的个体胰岛素使用几率较低(OR:0.27,CI:0.08 - 0.91)。还发现与开具的口服抗糖尿病药物总数存在显著关联(四种药物;OR:15.6,五种药物;OR:9.1)。其他因素未显示出显著关联。回归模型显示,低至7.9%的HbA1c水平可能表明22%的患者未来需要胰岛素治疗。

结论

该研究概述了需要或不需要胰岛素的T2DM患者在特征和参数方面的差异,并突出了印度T2DM患者开始使用胰岛素的挑战。关于II的研究结果强调了及时强化治疗的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d2/11610898/10bb9fb29b73/JFMPC-13-4244-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验